Beijing BIOOCUS Biotech Ltd. is a leading immune cell therapy company specializing in the development and production of innovative immune cell therapies for the treatment of various diseases. Our flagship product, ImmunoCell-101, is a cutting-edge cellular therapy designed to harness the power of the immune system to target and eliminate cancer cells, ImmunoCell-101 is created using advanced cell isolation and expansion techniques, resulting in a highly potent and specific immune cell population. These engineered immune cells have demonstrated remarkable efficacy in preclinical and clinical studies, showing the ability to selectively target and destroy cancer cells while minimizing damage to healthy tissue, Our team of experienced researchers and medical professionals are dedicated to advancing the field of immune cell therapy and improving outcomes for patients with cancer and other challenging diseases. We are committed to developing safe and effective treatments that have the potential to transform the landscape of cancer care. At Beijing BIOOCUS Biotech Ltd., we are proud to be at the forefront of immune cell therapy innovation, and we are excited to bring ImmunoCell-101 to patients in need
Please feel free to give your inquiry in the form below We will reply you in 24 hours